Deakin Health Economics, School of Health and Social Development, Deakin University, Geelong, Australia.
School of Public Health, The University of Queensland, Herston, Queensland, Australia.
Int J Eat Disord. 2017 Dec;50(12):1356-1366. doi: 10.1002/eat.22786. Epub 2017 Oct 16.
Anorexia nervosa (AN) is a prevalent, serious mental disorder. We aimed to evaluate the cost-effectiveness of family-based treatment (FBT) compared to adolescent-focused individual therapy (AFT) or no intervention within the Australian healthcare system.
A Markov model was developed to estimate the cost and disability-adjusted life-year (DALY) averted of FBT relative to comparators over 6 years from the health system perspective. The target population was 11-18 year olds with AN of relatively short duration. Uncertainty and sensitivity analyses were conducted to test model assumptions. Results are reported as incremental cost-effectiveness ratios (ICER) in 2013 Australian dollars per DALY averted.
FBT was less costly than AFT. Relative to no intervention, the mean ICER of FBT and AFT was $5,089 (95% uncertainty interval (UI): dominant to $16,659) and $51,897 ($21,591 to $1,712,491) per DALY averted. FBT and AFT are 100% and 45% likely to be cost-effective, respectively, at a threshold of AUD$50,000 per DALY averted. Sensitivity analyses indicated that excluding hospital costs led to increases in the ICERs but the conclusion of the study did not change.
FBT is the most cost-effective among treatment arms, whereas AFT was not cost-effective compared to no intervention. Further research is required to verify this result.
神经性厌食症(AN)是一种普遍且严重的精神障碍。本研究旨在评估基于家庭的治疗(FBT)与针对青少年的个体治疗(AFT)或不干预措施在澳大利亚医疗保健系统中的成本效益。
我们开发了一个马尔可夫模型,以评估 FBT 相对于比较组在 6 年内从医疗系统角度来看的成本效益,即相对短期的 AN 11-18 岁青少年患者的 FBT 相对于比较组的治疗成本和残疾调整生命年(DALY)节省。目标人群为相对短期的 AN 11-18 岁青少年患者。进行了不确定性和敏感性分析以检验模型假设。结果以每节省一个 DALY 的增量成本效益比(ICER)报告,单位为 2013 年澳元。
FBT 的成本低于 AFT。与不干预相比,FBT 和 AFT 的平均 ICER 分别为 5089 澳元(95%不确定区间[UI]:支配性至 16659 澳元)和 51897 澳元(21591 至 1712491 澳元)。FBT 和 AFT 分别有 100%和 45%的可能性在节省一个 DALY 的阈值为 50000 澳元时具有成本效益。敏感性分析表明,排除医院费用会导致 ICER 增加,但不会改变研究结论。
在治疗方案中,FBT 是最具成本效益的,而 AFT 与不干预相比则不具有成本效益。需要进一步研究来验证这一结果。